InvestorsHub Logo
Followers 1
Posts 252
Boards Moderated 0
Alias Born 02/23/2024

Re: None

Tuesday, 03/12/2024 1:53:48 PM

Tuesday, March 12, 2024 1:53:48 PM

Post# of 6885
"After having completed a Phase III registrational trial investigating its treatment for diarrhoea related to cancer care called Mytesi (crofelemer), Jaguar Health is planning for a readout before the end of H2, said the company’s CEO, Lisa Conte."

jesus fucking christ LISA done pushed the readout to EOY..... according to this artcile posted today https://www.pharmaceutical-technology.com/news/jaguar-health-balances-ambitions-for-human-and-animal-pharmaceuticals/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent JAGX News